External reports (aggregated public sources), Value Investors Club

Value Investors Club (VIC)

External reports (aggregated public sources)

Value Investors Club

Equity Bottom-Up

<ul><li>EHAB is undervalued at 6x FCFE</li><li>EHAB can increase profitability by focusing on Medicare Advantage plans and fee-for-service patients</li><li>Home health and hospice industry is growing, making EHAB an attractive investment with potential for consolidation in the sector</li></ul>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

EHAB is undervalued at 6x FCFEEHAB can increase profitability by focusing on Medicare Advantage plans and fee-for-service patientsHome health and hospice industry is growing, making EHAB an attractive investment with potential for consolidation in the sectorThis content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Enhabit, Inc. (EHAB) - Wednesday, Oct 23, 2024

Key points<ul><li>Enhabit Inc., the Home Health &amp; Hospice unit spun off from Encompass Health, is undergoing a strategic review that could result in a potential sale of the company.</li><li>Analysts estimate that if the company is sold, it could fetch a price 50-100% higher than its current value, with a potential equity value of $1.0bn or $20 per share.</li><li>The opportunity for a sale exists due to the company's undervaluation compared to its parent company, Encompass Health, as well as negative surprises in CMS rates and missed guidance, leading to activist pressure and a strategic review.</li></ul>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Key pointsEnhabit Inc., the Home Health &amp; Hospice unit spun off from Encompass Health, is undergoing a strategic review that could result in a potential sale of the company.Analysts estimate that if the company is sold, it could fetch a price 50-100% higher than its current value, with a potential equity value of $1.0bn or $20 per share.The opportunity for a sale exists due to the company's undervaluation compared to its parent company, Encompass Health, as well as negative surprises in CMS rates and missed guidance, leading to activist pressure and a strategic review.This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Enhabit Inc (EHAB) - Monday, Nov 27, 2023

United States

Enhabit, Inc. provides health care services. The Company offers evidence-based and disease-specific home health and hospice services. Enhabit serves patients in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Enhabit (EHAB US)

Enhabit, Inc. (EHAB) - Wednesday, Oct 23, 2024

Home health and hospice industry is growing, making EHAB an attractive investment with potential for consolidation in the sector

Value Investors Club (VIC)

Enhabit Inc (EHAB) - Monday, Nov 27, 2023

Enhabit Inc., the Home Health & Hospice unit spun off from Encompass Health, is undergoing a strategic review that could result in a potential sale...

Value Investors Club (VIC)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)